Elizabeth Holmes, the once-celebrated founder of Theranos whose promises of revolutionary medicine unraveled into one of Silicon Valley's most consequential frauds, has been approved to transition from federal prison to a halfway house in August 2027. The approval marks a measured step through the federal corrections system — not freedom, but a loosening of the strictest constraints — as Holmes continues to serve her sentence for defrauding the investors who believed in her vision. Her case remains a parable about ambition, deception, and the long arc of institutional accountability.